United States Defibrillator Market Size, Share, and COVID-19 Impact Analysis, By Product (EDs and ICDs), By End-use (Hospital, Public Access Market, Alternate Care Market, Home Healthcare, and Pre-hospital), and United States Defibrillator Market Insights, Industry Trend, Forecasts to 2035.

United States Defibrillator Market Insights Forecasts to 2035

• The US Defibrillator Market Size Was Estimated at USD 2,813.1 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 7.40% from 2025 to 2035
• The US Defibrillator Market Size is Expected to Reach USD 6,169.9 Million by 2035

According to a research report published by Spherical Insights & Consulting, The United States Defibrillator Market Size is anticipated to reach USD 6,169.9 Million by 2035, growing at a CAGR of 7.40% from 2025 to 2035. The expansion of the United States defibrillator market is propelled by the ageing population's higher prevalence of cardiovascular disorders and increasing susceptibility to cardiac events.

Market Overview

A defibrillator is a medical device that discharges regulated electricity to the heart to restore a normal cardiac rhythm in cardiac arrest patients suffering from potentially fatal arrhythmias such as ventricular fibrillation or pulseless ventricular tachycardia. Some of the key drivers of market growth include increased product development activities, an increase in sudden cardiac arrest occurrences, public awareness, and supportive initiatives by government and healthcare organizations. Additionally, some of the essential factors that are expected to significantly contribute to market growth include the increasing elderly population and technological advances. A defibrillator is typically used to shock the heart with electricity to restore a normal cardiac rhythm, since the elderly, particularly those 65 and older, are more prone to chronic conditions such as cardiovascular diseases (CVD). To illustrate, the senior population statistics, a portrait of ageing article published in November 2022, indicated that in the USA, about 54.1 million (16.3%) people were aged 65 years and older. Thus, the ageing population is attributed to the increasing demand for the product. Defibrillators are important for dealing with the issues of cardiovascular diseases, which contribute to the growth of the market. Defibrillator makers are actively and aggressively addressing the growing burden of CVDs with innovative products, which leads to market development. In the first half of 2021.

Report Coverage

This research report categorizes the market for the United States defibrillator market based on various segments and regions and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the United States defibrillator market. Recent market developments and competitive strategies such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the United States defibrillator market.

Driving Factors

The market for defibrillators in the US is expanding because defibrillator industry trends are evolving quickly. Government, healthcare, and communities are implementing PAD programs more quickly as a result of increased awareness of sudden cardiac arrest. The purpose of these programs is to improve public access to defibrillation, making them more publicly available in workplaces, schools, sporting venues, and airports. Defibrillators are currently, or are expected to be, very evenly spread over many different locations, increasing the likelihood of access to a defibrillator in many emergencies and increasing the chance of saved lives. Automatic external defibrillators, or AEDs, are designed to be simple enough for a non-medical user to operate.

Restraining Factors

The United States defibrillator market faces obstacles, like technical issues that are frequently linked to hardware and battery issues. Similarly, faulty electronics, wiring, and connectors are included. These problems are frequent, in addition to not producing an electric shock in the allotted period.

Market Segmentation

The United States defibrillator market share is classified into product and end-use.

• The ICDs segment held the largest market share in 2024 and is expected to grow at a remarkable CAGR during the forecast period.

The United States defibrillator market is segmented by product into EDs and ICDs. Among these, the ICDs segment held the largest market share in 2024 and is expected to grow at a remarkable CAGR during the forecast period. The high prevalence of CVDs, the sizable senior population in important markets, and the advancements in significant businesses' goods are the main drivers of this industry. As a specific example, Boston Scientific began the MODULAR ATP clinical study in December 2021 to assess the mCRM modular therapy system, concerning performance, safety, and efficacy. The study for the mCRM System, which consists of two cardiac rhythm management devices (including the EMBLEM MRI subcutaneous implantable defibrillator (S-ICD) system plus one additional component), is designed to fully review the system's capabilities.

• The hospital segment held the highest revenue share in 2024 and is expected to grow at a significant CAGR during the forecast period.

Based on the end-use, the United States defibrillator market is segmented into hospital, public access market, alternate care market, home healthcare, and pre-hospital. Among these, the hospital segment held the highest revenue share in 2024 and is expected to grow at a significant CAGR during the forecast period. The segmental growth is propelled by the higher volume of cardiac procedures and, therefore, cardiac patients being treated in hospitals. Both external defibrillators and ICDs are used in hospitals for the treatment of patients who develop sudden cardiac arrest, as well as for other.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the United States defibrillator market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Boston Scientific Corporation
• Abbott 
• ZOLL Medical Corporation
• Medtronic
• Stryker
• Koninklijke Philips N.V
• Nihon Kohden Corporation
• BIOTRONIK SE & Co. KG
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at the United States, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the United States defibrillator market based on the following segments:

United States Defibrillator Market, By Product  

• EDs
• ICDs

United States Defibrillator Market, By End-Use

• Hospital
• Public Access Market
• Alternate Care Market
• Home Healthcare
• Pre-hospital